NCT00994071 2019-12-09A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS TumorsNational Institutes of Health Clinical Center (CC)Phase 1 Completed9 enrolled